Darmiyan

May 29, 2025

Darmiyan Receives FDA Approval for Post-Market Surveillance Study of BrainSee, the First-in-Class Clinical Test for Predicting Risk of Progression to Clinical Alzheimer's Disease

Dec 19, 2024

Darmiyan Enters Medicare GUIDE Program Through Partnership with Five Star Home Health Care, CareBrains, and Brain Watch Coalition

Sep 16, 2024

Darmiyan, Inc. Announces Launch of Groundbreaking BrainSee Platform for Alzheimer's Testing

May 02, 2024

MCRA Supports Darmiyan with FDA Approval for BrainSee Device

Jan 12, 2024

Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia

Aug 11, 2020

The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer's-related abnormalities

Apr 10, 2020

Global Pharma Giant Eisai Leads a $6M Series Seed Investment Round in Darmiyan to Expedite its Clinical Market Entry